|
Volumn 21, Issue 18, 2000, Pages 1494-1495
|
Non-invasive baroreflex testing should be used to assess prognosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PHENYLEPHRINE;
ARTERIAL PRESSURE;
AUTONOMIC DYSFUNCTION;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC PROCEDURE;
EDITORIAL;
HEART FAILURE;
HEART INFARCTION;
HEART RATE VARIABILITY;
HUMAN;
INTERMETHOD COMPARISON;
PRESSORECEPTOR REFLEX;
PRIORITY JOURNAL;
PROGNOSIS;
RISK ASSESSMENT;
RR INTERVAL;
VALIDATION PROCESS;
AUTONOMIC NERVOUS SYSTEM;
BAROREFLEX;
HUMANS;
MYOCARDIAL INFARCTION;
PHENYLEPHRINE;
PROGNOSIS;
SENSITIVITY AND SPECIFICITY;
VASOCONSTRICTOR AGENTS;
|
EID: 0033821912
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1053/euhj.2000.2196 Document Type: Editorial |
Times cited : (4)
|
References (12)
|